Bumetanide continuous-infusion dosing in critically ill pediatric patients

被引：5

作者：

Bulkley, Christina F. ^{[1
]}

Johnson, Peter N. ^{[3
]}

Henry, Emilie ^{[2
]}

Harrison, Donald ^{[3
]}

Lewis, Teresa V. ^{[3
]}

Miller, Jamie L. ^{[3
]}

机构：

[1] Univ Oklahoma, Coll Pharm, Dept Pharm, Off Experiential Educ, Oklahoma City, OK 73117 USA

[2] Univ Oklahoma, Coll Med, Dept Pediat, Sect Crit Care, Oklahoma City, OK 73117 USA

[3] Univ Oklahoma, Coll Pharm, Dept Pharm Clin & Adm Sci, Oklahoma City, OK 73117 USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2012年 / 69卷 / 17期

关键词：

PHARMACOKINETICS; INFANTS; PHARMACODYNAMICS;

D O I：

10.2146/ajhp120056

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1458 / +

页数：3

共 9 条

[1]

[Anonymous], 2012, FUROSEMIDE MONOGRAPH

[2]

LopezSamblas AM, 1997, BIOL NEONATE, V72, P265

[3] Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients [J].

Marshall, JD ;

Wells, TG ;

Letzig, L ;

Kearns, GL .

JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (11) :994-1002

[4] The use of bumetanide for oliguric acute renal failure in preterm infants [J].

Oliveros, Milette ;

Pham, Jennifer T. ;

John, Eunice ;

Resheidat, Ashraf ;

Bhat, Rama .

PEDIATRIC CRITICAL CARE MEDICINE, 2011, 12 (02) :210-214

[5]

SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571

[6] Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants [J].

Sullivan, JE ;

Witte, JK ;

Yamashita, TS ;

Myers, CM ;

Blumer, JL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (04) :424-434

[7] Pharmacokinetics of bumetanide in critically ill infants [J].

Sullivan, JE ;

Witte, MK ;

Yamashita, TS ;

Myers, CM ;

Blumer, JL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (04) :405-413

[8] Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants [J].

Sullivan, JE ;

Witte, MK ;

Yamashita, TS ;

Myers, CM ;

Blumer, JL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (04) :414-423

[9] Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration [J].

Wakelkamp, M ;

Alvan, G ;

Gabrielsson, J ;

Paintaud, G .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (01) :75-88

← 1 →